glp 1 cardiovascular disease A new Science Perspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including and neurodegenerative disorders The cardiovascular effects of GLP-1

Curr Oncol Rep 2004

Chao Zheng, PhD, from The Second Affiliated Hospital, School of Medicine, Zhejiang University in Hangzhou, China, and team sought to expand the potential patient populations who can benefit by exploring novel peptide-based therapies, citing GLP-1RAs lack of effectiveness in a significant proportion of patients

Instead of viewing GLP-1s as a never-ending prescription, we consider them a catalyst for creating lasting lifestyle change

Regular lysine supplementation alleviates acute attacks and reduces the recurrence of a new infection

Its influence on intracellular repair signaling networks has led to growing research interest within experimental sports science and orthopedic models focused on tissue adaptation and recovery (4,5)